On Thursday, the CDC recommended that Americans receive the Pfizer or Moderna COVID-19 vaccines over the Johnson & Johnson vaccine due to rare but serious blood clots resulting from Johnson & Johnson’s.
“The strange clotting problem has caused nine confirmed deaths after J&J vaccinations — while the Pfizer and Moderna vaccines don’t come with that risk and also appear more effective, said advisers to the Centers for Disease Control and Prevention,” the Associated Press reported, adding, “Until now the U.S. has treated all three COVID-19 vaccines available to Americans as an equal choice, since large studies found they all offered strong protection and early supplies were limited. J&J’s vaccine initially was welcomed as a single-dose option that could be especially important for hard-to-reach groups like homeless people who might not get the needed second dose of the Pfizer or Moderna options.”
“Today, the CDC is endorsing updated recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the prevention of COVID-19, expressing a clinical preference for individuals to receive an mRNA COVID-19 vaccine over Johnson & Johnson’s COVID-19 vaccine,” Breaking911 reported. “ACIP’s unanimous recommendation followed a discussion of the latest evidence on vaccine effectiveness, vaccine safety and adverse events, such as blood clots.”
https://twitter.com/Breaking911/status/1471582403084922880?s=20
CDC Director Rochelle Walensky reportedly said, “We have made important strides in the year since the COVID-19 vaccination program started. More than 200 million Americans have completed their primary vaccine series, providing protection against COVID-19, preventing millions of cases and hospitalizations, and saving over a million lives. Today’s updated recommendation emphasizes CDC’s commitment to provide real-time scientific information to the American public. I continue to encourage all Americans to get vaccinated and boosted.”
